Business Wire

NY-ESTÉE-LAUDER

25.1.2021 14:02:10 CET | Business Wire | Press release

Share
The Estée Lauder Companies Announces Supply Chain Leadership Updates

Today The Estée Lauder Companies (NYSE:EL) announced that after nearly 13 years with the company, Gregory F. Polcer, Executive Vice President, Global Supply Chain, has made the decision to retire, effective July 1, 2021. He will be succeeded by Roberto Canevari, who will assume the role of Executive Vice President, Global Supply Chain, effective May 1, 2021. Roberto will report directly to Fabrizio Freda, President and Chief Executive Officer. Greg will work closely with Roberto over the next several months to support a smooth and successful transition.

“Greg has led ELC’s Global Supply Chain with a great blend of strategic insight and innovative thinking,” said Mr. Freda. “He has evolved our Supply Chain organization into a truly integrated, state-of-the-art global network that touches all aspects of our business and drives tremendous value. He has also been instrumental in elevating and operationalizing our core principles of safety and sustainability, and has been an enthusiastic and vocal champion of Inclusion & Diversity within his team and across the enterprise. Greg’s genuinely positive energy, enthusiastic leadership style and unique interdisciplinary expertise will be truly missed.”

“I am thrilled to welcome Roberto to The Estée Lauder Companies,” continued Mr. Freda. “He is a highly respected and talented supply chain expert and global leader who has successfully helmed and transformed the end-to-end supply chain organizations of several global, luxury, and brand-led companies. Throughout his career, he has consistently driven exceptional product quality and customer experience, as well as forward-looking sustainability strategies and practices. Roberto brings a unique combination of operational expertise and creative passion to ELC. I look forward to partnering closely with him to continue to innovate and improve our world-class supply chain organization.”

Please find further information about Gregory’s tenure and Roberto’s appointment below.

Gregory F. Polcer to Retire as Executive Vice President, Global Supply Chain

A strategic expert in his field, Greg leveraged his unique background in general management and finance to lead ELC’s Supply Chain organization to continuously adapt ahead of an increasingly complex global landscape. He has developed and nurtured strong relationships with top suppliers and organizations around the world, prioritizing collaboration and innovation to responsibly and ethically create the most luxurious, efficacious and safe beauty products, with sustainability in mind. Greg was particularly influential in strategizing and implementing ELC’s approach to responsible sourcing principles for sensitive supply chain and human rights issues. He also led the development of new manufacturing and distribution centers in several key regions, focused on global supply sufficiency. Under his leadership, ELC’s manufacturing and distribution sites maintained safety as their top priority.

Greg was a key architect of the company’s Global Corporate Citizenship and Sustainability (GCCS) function, and, through his work with the Global Environmental Affairs and Safety (EAS) team, led many of the initiatives that set the foundation for the company’s GCCS goals, particularly in the area of environmental operations.

A champion and steward of ELC’s core values, Greg’s innovative and inclusive team-building approach is reflected in an exceptional supply chain organization that has continuously driven best practices in quality and safety, while fostering an integrated culture of collaboration across the enterprise.

Greg’s longstanding commitment to Inclusion & Diversity included supporting and nurturing the Women in Supply Chain Employee Resource Group, which currently has more than 200 active members globally. Additionally, together with Sara Moss, Vice Chairman, Greg recently became a co-Executive Sponsor for the Open Doors Women’s Leadership Training Pilot Program, a new leadership development program that provides employees with experiential learning and executive coaching opportunities.

“I am deeply proud of all that my team and I have accomplished,” said Greg Polcer. “ELC’s Supply Chain has consistently advanced ahead of the curve, successfully collaborating and innovating to sustainably, responsibly and ethically deliver the most sought-after beauty products in the world. While the decision to retire is of course bittersweet, I know that the incredible Supply Chain team – with Roberto’s deep expertise and natural leadership abilities at the helm – is positioned well for its next chapter of growth.”

Roberto Canevari Appointed Executive Vice President, Global Supply Chain

As Executive Vice President, Global Supply Chain, Roberto will oversee the company’s Global Supply Chain operations, including end-to-end procurement, manufacturing, planning, quality assurance and logistics for our diverse brand portfolio across all channels and geographies. He will work to develop and implement innovative strategies and solutions to meet and exceed the demands of our global consumers, while partnering closely with brand and function leaders to leverage emerging trends, drive innovation and continuously improve processes. Additionally, building on the company’s long-term, outstanding relationships with global suppliers, Roberto’s focus will include strengthening and strategically evolving partnership models, prioritizing safety, sustainability, and responsible sourcing to help continue to create the most luxurious and efficacious beauty products.

Roberto has held supply chain leadership roles across a variety of industries. He most recently served as Unilever PLC’s Executive Vice President of Supply Chain, Europe, where he oversaw end-to-end supply chain operations for the company’s European business, and was responsible for a team of more than 10,000 employees and 44 factories with production across the food, home and personal care categories. Prior to that, Roberto was Chief Supply Chain Officer at Burberry Group PLC for nearly seven years, where he transformed the company’s global supply chain scope and strategy, developing new methods for omnichannel fulfillment and leveraging manufacturing resources to manage upstream quality.

Among his key achievements at Burberry, Roberto led the improvement of service-to-consumer KPIs and continuously elevated product quality, while improving cost performance to meet margin targets. Notably, he also played a significant role in Burberry’s Responsibility and Sustainability agenda, helping lead the company to be consistently listed at the top of the Dow Jones Sustainability Index for their industry globally.

Prior to his time with Burberry, Roberto served in executive supply chain roles of increasing responsibility at several high-profile global companies, including as Group Supply Chain Executive Director at Carrefour SA. He also spent a number of years at Nestlé, leading supply chain and procurement operations for Nestlé Water.

Originally from Italy, Roberto holds a degree in Industrial Engineering from the Politecnico of Milan. He is currently a member of the Executive Advisory Board of Gartner Supply Chain, a leading organization in supply chain research and development. He has also held leadership roles at SOS-Logistica, an association working to promote sustainability and safety initiatives across logistics and supply chain processes.

“I am thrilled to be joining The Estée Lauder Companies,” said Roberto Canevari. “Greg has done a truly incredible job developing and leading a uniquely talented and dynamic global Supply Chain organization. It is an honor to step into this role, and I am eager to continue to build on the success of this critical function. I look forward to partnering with Fabrizio and the entire Executive Leadership Team to contribute to the overall success and continued growth of ELC.”

Forward-Looking Statements

Certain statements in this press release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may address our expectations regarding supply chain matters, sales, earnings or other future financial performance and liquidity, other performance measures, product introductions, entry into new geographic regions, information technology initiatives, new methods of sale, our long-term strategy, restructuring and other charges and resulting cost savings, and future operations or operating results. Although we believe that our expectations are based on reasonable assumptions within the bounds of our knowledge of our business and operations, we cannot assure that actual results will not differ materially from our expectations. Factors that could cause actual results to differ from expectations are described in our Form 10-K for fiscal 2020. We assume no responsibility to update forward-looking statements made herein or otherwise.

About The Estée Lauder Companies Inc.

The Estée Lauder Companies Inc. is one of the world’s leading manufacturers and marketers of quality skin care, makeup, fragrance and hair care products. The company’s products are sold in approximately 150 countries and territories under brand names including: Estée Lauder, Aramis, Clinique, Lab Series, Origins, Tommy Hilfiger, M·A·C, La Mer, Bobbi Brown, Donna Karan New York, DKNY, Aveda, Jo Malone London, Bumble and bumble, Michael Kors, Darphin, TOM FORD BEAUTY, Smashbox, Ermenegildo Zegna, AERIN, RODIN olio lusso, Le Labo, Editions de Parfums Frédéric Malle, GLAMGLOW, KILIAN PARIS, BECCA, Too Faced and Dr. Jart+.

ELC-L
ELC-C

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye